These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 3491604)
1. The interaction of bovine factor IX, its activation intermediate, factor IX alpha, and its activation products, factor IXa alpha and factor IXa beta, with acidic phospholipid vesicles of various compositions. Beals JM; Castellino FJ Biochem J; 1986 Jun; 236(3):861-9. PubMed ID: 3491604 [TBL] [Abstract][Full Text] [Related]
2. Comparison of lipid binding and kinetic properties of normal, variant, and gamma-carboxyglutamic acid modified human factor IX and factor IXa. Jones ME; Griffith MJ; Monroe DM; Roberts HR; Lentz BR Biochemistry; 1985 Dec; 24(27):8064-9. PubMed ID: 3879187 [TBL] [Abstract][Full Text] [Related]
4. Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X. Castillo MJ; Kurachi K; Nishino N; Ohkubo I; Powers JC Biochemistry; 1983 Mar; 22(5):1021-9. PubMed ID: 6601494 [TBL] [Abstract][Full Text] [Related]
5. The kinetic assembly of the intrinsic bovine factor X activation system. Beals JM; Chibber BA; Castellino FJ Arch Biochem Biophys; 1989 Feb; 268(2):485-501. PubMed ID: 2492418 [TBL] [Abstract][Full Text] [Related]
6. Molecular interactions of the intrinsic activation complex of coagulation: binding of native and activated human factors IX and X to defined phospholipid vesicles. Burri BJ; Edgington TS; Fair DS Biochim Biophys Acta; 1987 Feb; 923(2):176-86. PubMed ID: 3493031 [TBL] [Abstract][Full Text] [Related]
7. Binding of human blood-coagulation Factors IXa and X to phospholipid membranes. Mertens K; Cupers R; Van Wijngaarden A; Bertina RM Biochem J; 1984 Nov; 223(3):599-605. PubMed ID: 6334516 [TBL] [Abstract][Full Text] [Related]
8. Binding of factors IX and IXa to cultured vascular endothelial cells. Stern DM; Drillings M; Nossel HL; Hurlet-Jensen A; LaGamma KS; Owen J Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4119-23. PubMed ID: 6602986 [TBL] [Abstract][Full Text] [Related]
9. The contribution of Ca2+ and phospholipids to the activation of human blood-coagulation Factor X by activated Factor IX. Mertens K; Bertina RM Biochem J; 1984 Nov; 223(3):607-15. PubMed ID: 6334517 [TBL] [Abstract][Full Text] [Related]
10. The binding of calcium to the activation products of bovine factor IX. Amphlett GW; Byrne R; Castellino FJ J Biol Chem; 1979 Jul; 254(14):6333-6. PubMed ID: 447718 [TBL] [Abstract][Full Text] [Related]
11. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex. Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238 [TBL] [Abstract][Full Text] [Related]
12. Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid. van Dieijen G; van Rijn JL; Govers-Riemslag JW; Hemker HC; Rosing J Thromb Haemost; 1985 Jun; 53(3):396-400. PubMed ID: 3931288 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the clotting activities of structurally different forms of activated factor IX. Enzymatic properties of normal human factor IXa alpha, factor IXa beta, and activated factor IX Chapel Hill. Griffith MJ; Breitkreutz L; Trapp H; Briet E; Noyes CM; Lundblad RL; Roberts HR J Clin Invest; 1985 Jan; 75(1):4-10. PubMed ID: 3871202 [TBL] [Abstract][Full Text] [Related]
14. Metal ion specificity of the conversion of bovine factors IX, IX alpha, and IXa alpha to bovine factor IXa beta. Byrne R; Amphlett GW; Castellino FJ J Biol Chem; 1980 Feb; 255(4):1430-5. PubMed ID: 7354038 [No Abstract] [Full Text] [Related]
15. Characterization of the functional defect in factor IX Alabama. Evidence for a conformational change due to high affinity calcium binding in the first epidermal growth factor domain. McCord DM; Monroe DM; Smith KJ; Roberts HR J Biol Chem; 1990 Jun; 265(18):10250-4. PubMed ID: 2355000 [TBL] [Abstract][Full Text] [Related]
16. Identification of a factor IX/IXa binding protein on the endothelial cell surface. Rimon S; Melamed R; Savion N; Scott T; Nawroth PP; Stern DM J Biol Chem; 1987 May; 262(13):6023-31. PubMed ID: 3032954 [TBL] [Abstract][Full Text] [Related]
17. Activation of factor IX zymogen results in exposure of a binding site for low-density lipoprotein receptor-related protein. Neels JG; van Den Berg BM; Mertens K; ter Maat H; Pannekoek H; van Zonneveld AJ; Lenting PJ Blood; 2000 Nov; 96(10):3459-65. PubMed ID: 11071642 [TBL] [Abstract][Full Text] [Related]
18. Activation of factor IX bound to cultured bovine aortic endothelial cells. Stern DM; Drillings M; Kisiel W; Nawroth P; Nossel HL; LaGamma KS Proc Natl Acad Sci U S A; 1984 Feb; 81(3):913-7. PubMed ID: 6608105 [TBL] [Abstract][Full Text] [Related]
19. The effect of calcium on the thermotropic properties of bovine blood coagulation factors IX and X and their activation intermediates and products. Link RP; Castellino FJ Arch Biochem Biophys; 1983 Nov; 227(1):259-65. PubMed ID: 6639079 [TBL] [Abstract][Full Text] [Related]
20. Activation of normal and abnormal human factor IX with trypsin. Monroe DM; Noyes CM; Straight DL; Roberts HR; Griffith MJ Arch Biochem Biophys; 1985 May; 238(2):490-6. PubMed ID: 3873217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]